Dr Fritz Kunz joins PregLem's board of directors
This article was originally published in Scrip
Executive Summary
PregLem, a Swiss speciality biopharmaceutical company developing and commercialising compounds for the treatment of major benign gynaecological conditions and infertility, has appointed Dr Fritz Kunz to its board of directors. He is chairman of the board of Speedel and Kuros Biosurgery, and also serves on the board of Straumann Holding, Sentec and Allevia.